Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352807
Status:
COMPLETED
Last Update Posted:
2007-10-17
First Post:
2006-07-14
Brief Title:
Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients
Sponsor:
Indiana University School of Medicine
Organization:
Indiana University
Study Overview
Official Title:
Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to obtain and assay human aqueous samples following pre-operative dosing with 01 Brimonidine Purite pH 78 or with 015 Brimonidine Purite pH 72 from patients undergoing routine cataract surgery in order to evaluate the aqueous concentration of the two formulationsStudy hypothesis The aqueous humor concentration 45 minutes following dosing of 01 Brimonidine Purite pH 78 is comparable with 015 Brimonidine Purite pH 72
Detailed Description:
The purpose of this study is to obtain and assay human aqueous samples following pre-operative dosing with 01 Brimonidine Purite pH 78 or with 015 Brimonidine Purite pH 72 from patients undergoing routine cataract surgery in order to evaluate the aqueous concentration of the two formulations
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None